FHI vs HLNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 01, 2026

FHI

58.4
AI Score
VS
FHI Wins

HLNE

44.7
AI Score

Investment Advisor Scores

FHI

58score
Recommendation
HOLD

HLNE

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric FHI HLNE Winner
Revenue 981.73M 275.33M FHI
Net Income 200.70M 80.46M FHI
Net Margin 20.4% 29.2% HLNE
ROE 16.0% 8.6% FHI
ROA 8.6% 3.2% FHI
Total Assets 2.33B 2.54B HLNE
Debt/Equity 0.28 0.29 FHI
Free Cash Flow 103.69M 75.35M FHI

Relative Price Performance (Last 90 Days)

FHI 1M: -1.3% · 3M: +9.4% HLNE 1M: +4.7% · 3M: +28.1%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $62.40

HLNE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.0% over 20 days), RSI 54

RSI (14): 54.2 · Price: $103.06

Fundamentals Snapshot

Metric FHI HLNE
Market Cap
Forward P/E 10.6 17.2
Trailing P/E 11.3 15.7
Revenue (TTM)
Revenue Growth 0.2% 0.6%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.5%
EPS 5.51 6.57
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.